Multiple sclerosis patients who undergo infertility treatments have higher relapse rates. Multiple sclerosis can bring upon many health complications, infertility being one of them. Research published in Annals of Neurology found that multiple sclerosis patients who undergo assisted reproduction technology (ART) face a higher risk of disease activity and multiple sclerosis relapse.
Researcher Dr. Jorge Correale from the study said, “When MS and infertility coincide, patients seek ART to achieve pregnancy. Given the role of some reproductive hormones in autoimmune diseases, those with MS receiving infertility treatments are at particular risk of exacerbating their disease.”
The researchers analyzed clinical, radiological, and immune responses in 16 multiple sclerosis patients who underwent 26 ART cycles. The team recruited additional 15 MS patients not undergoing ART cycles and 15 healthy volunteers to participate as controls.
The findings uncovered that 75 percent of multiple sclerosis patients experienced worsening of the disease following the ART treatment. Fifty-eight percent of patients reported a relapse during the three months after the ART treatment. Patients also experienced worsening of existing symptoms, and some of them developed new symptoms.
Dr. Correale concluded, “Our findings indicate a significant increase in MS disease activity following infertility treatment. Neurologists should be aware of possible disease exacerbation so they may discuss the benefits and risks of ART with MS patients.”
Multiple sclerosis can affect fertility and pregnancy in different ways, and in turn pregnancy can affect MS in a variety of ways, too. Here are some of those effects that multiple sclerosis and pregnancy have on each other:
For women with multiple sclerosis, there are not too many risks associated with becoming pregnant and delivering the baby. As long as you speak with your doctor about your own unique special needs, they can advise you in the right direction and ensure you have a safe pregnancy.
Multiple sclerosis patients treated with Tysabri (natalizumab) have a 10 times greater risk of developing a deadly brain virus, according to new findings. The virus – John Cunningham virus (JCV) – is a pathogen that causes a rare and deadly condition known as progressive multifocal leukoencephalopathy (PML). The link between Tysabri and PML is not new. In fact, there have been numerous previous studies that have shown an increased risk of PML due to Tysabri use. Continue reading…
Multiple sclerosis fatigue linked with poor sleep and task length.
Whether we have multiple sclerosis (MS) or not, all of us feel some level of tiredness or fatigue at some point in our lives. However, multiple sclerosis fatigue is different from “normal” tiredness. People without multiple sclerosis have no problem in doing simple tasks such as going to the bank or going to the grocery store. But for individuals with MS, the fatigue can make even such simple tasks almost impossible. Continue reading…